Nora Shannon

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Transcription Factor

Left Ventricular

Hypertrophic Cardiomyopathy

Top Venues

Circulation. Genomic and precision medicine

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Jesse B G Hayesmoore, Michael Bowman, Nora Shannon, Edward Blair, Hugh C Watkins, Kate L Thomson
A Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans. Circulation. Genomic and precision medicine 17 (1) (2024)
Jesse B G Hayesmoore, Michael Bowman, Nora Shannon, Edward Blair, Hugh C Watkins, Kate L Thomson
A Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans. Circulation. Genomic and precision medicine 17 (1) (2024)
Jesse B G Hayesmoore, Michael Bowman, Nora Shannon, Edward Blair, Hugh C Watkins, Kate L Thomson
Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans. Circulation. Genomic and precision medicine (2024)
Jesse B G Hayesmoore, Michael Bowman, Nora Shannon, Edward Blair, Hugh C Watkins, Kate L Thomson
A Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans. Circulation. Genomic and precision medicine 17 (1) (2024)
Jesse B G Hayesmoore, Michael Bowman, Nora Shannon, Edward Blair, Hugh C Watkins, Kate L Thomson
A Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans. Circulation. Genomic and precision medicine 17 (1) (2024)
Riccardo Giuseppe Abbasciano, Giovanni Mariscalco, Julian Barwell, Gareth Owens, Mustafa Zakkar, Lathishia Joel-David, Suraj Pathak, Adewale Adebayo, Nora Shannon, Rebecca Louise Haines, Hardeep Aujla, Bryony Eagle-Hemming, Tracy Kumar, Florence Lai, Marcin Wozniak, Gavin Murphy
Evaluating the Feasibility of Screening Relatives of Patients Affected by Nonsyndromic Thoracic Aortic Diseases: The REST Study. Journal of the American Heart Association 11 (8) (2022)